Gastroenterology 136, 20032014
Diabetes Metab Syndrome Obes Targets Ther (2021) 14:295572
These drugs are part of an emerging class of nutrient-stimulated hormone-based therapeutics, acting as incretin mimetics to target G-proteincoupled receptors like GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon
This deficiency can lead to a host of symptoms, ranging from mild to severe, including metabolic acidosis, hemolytic anemia, and neurological impairments
Its scale reflects deep urban prescribing, broad reimbursement reach, and the strong role of domestic manufacturers in shaping access and pricing
Some people call it food noise